Hirai S

ORCID: 0000-0002-0803-5975 · 4 papers in corpus
diagnostic-accuracy 2026
Cancers ·doi:10.3390/cancers18132133

Background/Objectives: Endometrial cancer (EC) is the most prevalent gynecological malignancy in developed countries, yet no clinically validated noninvasive screening biomarker exists. Fatty acid metabolic reprogramming is a hallmark of ca…

diagnostic-accuracy 2024
Scientific reports ·doi:10.1038/s41598-024-71606-w

Despite widespread cervical cancer (CC) screening programs, low participation has led to high morbidity and mortality rates, especially in developing countries. Because early-stage CC often has no symptoms, a non-invasive and convenient dia…

diagnostic-accuracy 2023
Cancer research communications ·doi:10.1158/2767-9764.crc-23-0138

UNLABELLED: Ovarian cancer has a poor prognosis and is difficult to detect in early stages. Therefore, developing new diagnostic markers for early-stage ovarian cancer is critical. Here, we developed a diagnostic marker for early-stage ovar…

lab-animal 2013
Journal of applied toxicology : JAT ·doi:10.1002/jat.2713

Cadmium, one of various environmental toxicants, is known to suppress systemic immunity and to injure the testicular capillary endothelia with resultant necrosis of testicular tissues in mice and rats treated with high doses. Recently, it a…